Rhabdomyolysis precipitated by a sitagliptin-atorvastatin drug interaction

被引：19
作者：
Bhome, R. [1 ]
Penn, H. [1 ]
机构：
[1] Northwick Pk Hosp & Clin Res Ctr, Dept Rheumatol, Harrow HA1 3UJ, Middx, England
来源：
DIABETIC MEDICINE | 2012年 / 29卷 / 05期
关键词：
D O I：
10.1111/j.1464-5491.2011.03502.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Diabet. Med. 29, 693694 (2012)
引用
收藏
页码：693 / 694
页数：2
相关论文
共 5 条
  • [1] Efficacy and safety of treatment with sitagliptin or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy: a randomized, double-blind, non-inferiority trial
    Arechavaleta, R.
    Seck, T.
    Chen, Y.
    Krobot, K. J.
    O'Neill, E. A.
    Duran, L.
    Kaufman, K. D.
    Williams-Herman, D.
    Goldstein, B. J.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (02) : 160 - 168
  • [2] Safety of statins - Focus on clinical pharmacokinetics and drug interactions
    Bellosta, S
    Paoletti, R
    Corsini, A
    [J]. CIRCULATION, 2004, 109 (23) : 50 - 57
  • [3] Rhabdomyolysis Caused by a Potential Sitagliptin-Lovastatin Interaction
    DiGregorio, Robert V.
    Pasikhova, Yanina
    [J]. PHARMACOTHERAPY, 2009, 29 (03): : 352 - 356
  • [4] Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use
    Kao, D. P.
    Kohrt, H. E.
    Kugler, J.
    [J]. DIABETIC MEDICINE, 2008, 25 (10) : 1229 - 1230
  • [5] Metabolism and excretion of the dipeptidyl peptidase 4 inhibitor [14C]sitagliptin in humans
    Vincent, Stella H.
    Reed, James R.
    Bergman, Arthur J.
    Elmore, Charles S.
    Zhu, Bing
    Xu, Shiyao
    Ebel, David
    Larson, Patrick
    Zeng, Wei
    Chen, Li
    Dilzer, Stacy
    Lasseter, Kenneth
    Gottesdiener, Keith
    Wagner, John A.
    Herman, Gary A.
    [J]. DRUG METABOLISM AND DISPOSITION, 2007, 35 (04) : 533 - 538
1